A dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats

Obesity

Volumn 23, Issue 1, 2015, Pages 112-119

  Miller, Colette N ^a   Yang, Jeong Yeh ^b   Avra, Tucker ^b   Ambati, Suresh ^c   Della Fera, Mary Anne ^b   Rayalam, Srujana ^d   Baile, Clifton A ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c University of Georgia   (United States)

^d Department of Genetics University of Georgia ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; QUERCETIN; RESVERATROL; VITAMIN D; X BOX BINDING PROTEIN 1; PLANT MEDICINAL PRODUCT; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CELL REGENERATION; CONTROLLED STUDY; DIETARY INTAKE; FAT INTAKE; FATTY LIVER; FEMALE; FOOD COMPOSITION; GENE EXPRESSION; LIPID STORAGE; LIPOGENESIS; LIVER INJURY; MOBILIZATION; NONHUMAN; OVARIECTOMY; PHYTOCHEMISTRY; PROTEIN INTAKE; RAT; ANIMAL; COMPLICATION; DIET; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; FISCHER 344 RAT; LIPID METABOLISM; LIVER; METABOLISM; OBESITY;

RATTUS;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIET; DIETARY SUPPLEMENTS; FATTY LIVER; FEMALE; GENISTEIN; LIPID METABOLISM; LIVER; OBESITY; OVARIECTOMY; PHYTOCHEMICALS; RATS; RATS, INBRED F344; TRIGLYCERIDES;

EID: 84928262713     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20907     Document Type: Article

References (27)

1. Carr MC,. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404-2411.
2. Toth MJ, Tchernof A, Sites CK, Poehlman ET,. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obesity Relat Metab Disord 2000; 24: 226-231.
3. Simkin-Silverman LR, Wing RR,. Weight gain during menopause. Is it inevitable or can it be prevented? Postgraduate Med 2000; 108: 47-50, 53-46.
4. Adkins Y, Schie IW, Fedor D, et al. A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance. Lab Investig 2013; 93: 1313-1322.
5. Go GW, Oh S, Park M, et al. t10,c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation. J Microbiol Biotechnol 2013; 23: 1569-1576.
6. Warren JM, Simon VA, Bartolini G, Erickson KL, Mackey BE, Kelley DS,. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes. Lipids 2003; 38: 497-504.
7. Reddy JK, Rao MS,. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastro Liver Physiol 2006; 290: G852-G858.
8. Shang J, Chen LL, Xiao FX, Sun H, Ding HC, Xiao H,. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharm Sin 2008; 29: 698-706.
9. Kim MH, Kang KS, Lee YS,. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br J Nutr 2010; 104: 1333-1342.
10. Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC,. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Design 2013; 19: 6064-6093.
11. Park HJ, Yang JY, Ambati S, et al. Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food 2008; 11: 773-783.
12. Lai CY, Yang JY, Rayalam S, et al. Preventing bone loss and weight gain with combinations of vitamin D and phytochemicals. J Med Food 2011; 14: 1352-1362.
13. Zhu L, Brown WC, Cai Q, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 2013; 62: 424-434.
14. Hirota M, Kitagaki M, Itagaki H, Aiba S,. Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress. J Toxicol Sci 2006; 31: 149-156.
15. Folch J, Lees M, Sloane Stanley GH,. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
16. Nogowski L, Mackowiak P, Kandulska K, Szkudelski T, Nowak KW,. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 1998; 42: 360-366.
17. Watkins ML, Fizette N, Heimberg M,. Sexual influences on hepatic secretion of triglyceride. Biochim Biophys Acta 1972; 280: 82-85.
18. Kenagy R, Weinstein I, Heimberg M,. The effects of 17 beta-estradiol and progesterone on the metabolism of free fatty acid by perfused livers from normal female and ovariectomized rats. Endocrinology 1981; 108: 1613-1621.
19. Gomori A, Ishihara A, Ito M, et al. Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice. Br J Pharmacol 2007; 151: 900-908.
20. Paquette A, Wang D, Jankowski M, Gutkowska J, Lavoie JM,. Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver. Menopause 2008; 15: 1169-1175.
21. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ,. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Investig 2005; 115: 1343-1351.
22. Liu X, Strable MS, Ntambi JM,. Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv Nutr 2011; 2: 15-22.
23. Gutierrez-Juarez R, Pocai A, Mulas C, et al. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Investig 2006; 116: 1686-1695.
24. Masterjohn C, Bruno RS,. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev 2012; 70: 41-56.
25. Koek GH, Liedorp PR, Bast A,. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 2011; 412: 1297-1305.
26. Choi JS, Koh IU, Song J,. Genistein reduced insulin resistance index through modulating lipid metabolism in ovariectomized rats. Nutr Res 2012; 32: 844-855.
27. Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A,. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol 2012; 56: 952-964.